Contact
searchSearch
HMP Global

Stomach and Small Bowel Diseases News

Conference Coverage
E-Cigarette Use and Risk of Peptic Ulcer Disease: Findings from a National Cohort
10/27/2025
Rebecca Mashaw
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at...
10/27/2025
Gastroenterology
News
GLP-1 Receptor Agonists Linked to Lower Risk of Peptic Ulcer Disease in Patients with T2DM
09/04/2025
Jessica Garlewicz
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional...
09/04/2025
Gastroenterology
News
Global Escalation of H pylori Antibiotic Resistance Spurs Call for Action
07/24/2025
Rebecca Mashaw
Inconsistencies in reimbursement coverage, diagnostic tools available contribute to accessibility inequities for H pylori surveillance.
Inconsistencies in reimbursement coverage, diagnostic tools available contribute to accessibility inequities for H pylori surveillance.
Inconsistencies in reimbursement...
07/24/2025
Gastroenterology
News
Comparative Effectiveness of H Pylori Treatments
07/24/2025
Rebecca Mashaw
Researchers noted that clinicians should consider patients’ histories of antibiotic use when treating H pylori.
Researchers noted that clinicians should consider patients’ histories of antibiotic use when treating H pylori.
Researchers noted that...
07/24/2025
Gastroenterology
News
Vonoprozan Compared to PPIs for Peptic Ulcer Rebleeding Prevention
10/18/2024
Jessica Garlewicz
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective...
10/18/2024
Gastroenterology
stomach illustration
News
H pylori Eradication Assessed for Prevention of Gastric Cancer
09/18/2023
Rebecca Mashaw
Investigators sought to find out if eradicating Helicobacter pylori was associated with changes in the incidence of noncardia gastric adenocarcinoma.
Investigators sought to find out if eradicating Helicobacter pylori was associated with changes in the incidence of noncardia gastric adenocarcinoma.
Investigators sought to find out...
09/18/2023
Gastroenterology
FDA Alert
News
FDA Approves First Treatment for Pediatric Functional Constipation
06/20/2023
FDA has approved Linzess (linaclotide) capsules to treat functional constipation in pediatric patients 6 to 17 years of age.
FDA has approved Linzess (linaclotide) capsules to treat functional constipation in pediatric patients 6 to 17 years of age.
FDA has approved Linzess...
06/20/2023
Gastroenterology
Dr Azizullah Beran
Conference Coverage
Endoscopic Therapy Demonstrated Better Outcomes in Treating Bleeding PUDs with Adherent Clot
05/05/2023
Dr Azizullah Beran shed light on endoscopic vs conservative therapeutic approaches in managing bleeding peptic ulcer with adherent clots in his oral paper presentation at the 2022 ACG Annual Scientific Meeting.
Dr Azizullah Beran shed light on endoscopic vs conservative therapeutic approaches in managing bleeding peptic ulcer with adherent clots in his oral paper presentation at the 2022 ACG Annual Scientific Meeting.
Dr Azizullah Beran shed light on...
05/05/2023
Gastroenterology
News
H pylori Eradication Treatment May Reduce Gastric Cancer Risk
02/12/2022
The authors of a new study sought to determine whether H pylori eradication treatment reduces the risk of gastric cancer among those with a family history of gastric cancer in first-degree relatives.
The authors of a new study sought to determine whether H pylori eradication treatment reduces the risk of gastric cancer among those with a family history of gastric cancer in first-degree relatives.
The authors of a new study...
02/12/2022
Gastroenterology
News
Low FODMAP Diet Reduces Symptoms in Celiac Disease
02/04/2022
Short-term use of a low FODMAP diet should be considered in managing persistent symptoms in celiac disease, researchers say.
Short-term use of a low FODMAP diet should be considered in managing persistent symptoms in celiac disease, researchers say.
Short-term use of a low FODMAP...
02/04/2022
Gastroenterology

News

Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
Emerging Therapies
EC Plus FOLFIRI Improves Response Rates in First-Line BRAF V600E–Mutant Metastatic Colorectal Cancer
01/14/2026
Jessica Garlewicz
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating...
01/14/2026
Gastroenterology
Research Highlights
Short Course Radiation and ctDNA for Rectal Cancer
01/14/2026
Jessica Garlewicz
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the...
01/14/2026
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
01/14/2026
Jessica Garlewicz
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
01/14/2026
Gastroenterology
Research Highlights
Persistent MASLD Greatly Increases Diabetes and Cardiovascular Risks, Study Finds
12/15/2025
Rebecca Mashaw
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links...
12/15/2025
Gastroenterology
Research Highlights
Sex-Specific Risks Highlight MASLD Burden Across Women’s Lifespan
12/11/2025
Rebecca Mashaw
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD...
12/11/2025
Gastroenterology
Conference Coverage
Resmetirom Reduces Portal Hypertension Risk and Fibrosis Markers in MASH Cirrhosis at 2 Years
11/04/2025
Jessica Garlewicz
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients...
11/04/2025
Gastroenterology
Conference Coverage
Tirzepatide Bests Semaglutide in Reducing Cardiovascular Events and Mortality in Patients With MASLD/MASH
11/04/2025
Jessica Garlewicz
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was...
11/04/2025
Gastroenterology
Conference Coverage
E-Cigarette Use and Risk of Peptic Ulcer Disease: Findings from a National Cohort
10/27/2025
Rebecca Mashaw
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at...
10/27/2025
Gastroenterology
Research Highlights
Liquid Biopsy Shows Potential in Cholangiocarcinoma Care
10/09/2025
Rebecca Mashaw
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights...
10/09/2025
Gastroenterology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use